Funding Opportunity RFA-HG-19-013 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to participate in the Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network. This network will continue to use biorepositories linked with electronic medical records (EMRs) for genomic research by developing, evaluating, and disseminating genomic risk assessment and management tools for clinical use. Applicants to this FOA are expected to recruit a minimum of 35% of patients who come from racial or ethnic minority populations, underserved populations, or populations who experience poorer medical outcomes. In contrast, applicants to the companion RFA-HG-19-014 are expected to recruit a minimum of 75% of such patients.

Funding Opportunity RFA-HG-19-014 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to participate in the Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network. This network will continue to use biorepositories linked with electronic medical records (EMRs) for genomic research by developing, evaluating, and disseminating genomic risk assessment and management tools for clinical use. Applicants to this FOA are expected to recruit a minimum of 75% of patients who come from racial or ethnic minority populations, underserved populations, or populations who experience poorer medical outcomes. In contrast, applicants to the companion RFA-HG-19-013 are expected to recruit a minimum of 35% of such patients.

Funding Opportunity RFA-HG-19-015 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to continue genomic implementation research in the Electronic Medical Records and Genomics (eMERGE) Network by providing support for a Coordinating Center (CC) to provide centralized support, infrastructure, coordination, and data analysis for the program.

Competitive Salary: EMBL: Full Stack Developer Location: E Cambridge, Cambridgeshire, England

Funding Opportunity RFA-AG-20-025 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to support research focused on understanding the role of senescence in brain aging and in Alzheimer's disease (AD). This FOA encourages research projects addressing critical knowledge gaps in our understanding of the neurobiology of senescence through cutting-edge techniques, cross-disciplinary collaborations, and/or conceptual innovation, leveraging what is known about senescence in peripheral tissues to learn more about brain aging. Developing a clear understanding of the mechanisms driving aging processes in the brain, including senescence, is essential for combating age-related neurodegenerative diseases.

Funding Opportunity PAR-19-288 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to continue the operations of the NIA Genome Center for Alzheimer's Disease (GCAD) to facilitate and support the Alzheimer's Disease Sequencing Project (ADSP) activities. GCAD will serve as the focal point for all phases of ADSP quality control checking, data harmonization, and meta-analysis. The FOA is intended to support a major component of the full range of analysis for the ADSP. The spectrum of the Center's activities comprises a multidisciplinary attack on Alzheimer's Disease (AD) and AD Related Dementias (ADRD) in keeping with NIA's programmatic needs. The Center will serve as a national resource for the specific purpose of identifying potential avenues for therapeutic approaches and prevention of the disease.

Orion Corporation: Orion Corporation is a globally operating Finnish pharmaceutical company - a builder of well-being. Orion develops, manufactures and market Finland (FI)

Notice NOT-AA-19-016 from the NIH Guide for Grants and Contracts

Notice NOT-AA-19-018 from the NIH Guide for Grants and Contracts

Notice NOT-AA-19-017 from the NIH Guide for Grants and Contracts

Notice NOT-CA-19-052 from the NIH Guide for Grants and Contracts

Notice NOT-DA-19-045 from the NIH Guide for Grants and Contracts

Notice NOT-HL-19-700 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-19-287 from the NIH Guide for Grants and Contracts. The National Cancer Institutes (NCI) Cancer Systems Biology Consortium (CSBC) supports systems biology approaches to cancer research and includes U54 CSBC Research Centers, a U24 CSBC Coordinating Center and, through this FOA, well-defined, discrete and circumscribed U01 Research Projects. CSBC Research Projects are expected to involve interdisciplinary teams of scientists, engineers, and cancer researchers who collaborate to advance our understanding of the mechanisms underlying cancer initiation, progression, and treatment. CSBC Research Projects proposed in response to this Funding Opportunity Announcement must demonstrate explicit integration of experimental biology and computational modeling to test and validate novel hypotheses in cancer research.

Funding Opportunity RFA-AG-20-043 from the NIH Guide for Grants and Contracts. This funding opportunity will support a new, centralized infrastructure (U24) to aggregate, harmonize, manage, and share existing and future neuroimaging data collected in NIA- supported Alzheimer's Disease Research Centers (ADRCs).

Funding Opportunity RFA-DA-20-001 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIDA/NIMH R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs in the use of ABCD data. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on courses for skills development, particularly short-term workshops that will allow participants to explore the hands-on use of ABCD data, through cooperative or competitive approaches.

Notice NOT-AA-19-019 from the NIH Guide for Grants and Contracts

Notice NOT-DA-19-047 from the NIH Guide for Grants and Contracts

Provide statistical and computational tools for biologically based activities such as genetic analysis, measurement of gene expression, and gene function... $60,000 - $200,000 a year
From selfdecode.com - Wed, 22 May 2019 04:09:31 GMT - View all Ellsworth, WI jobs

Provide statistical and computational tools for biologically based activities such as genetic analysis, measurement of gene expression, and gene function... $60,000 - $200,000 a year
From selfdecode.com - Tue, 21 May 2019 22:04:09 GMT - View all Milwaukee, WI jobs